10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001213900-16-013088`
Period End Date	20160331
Filing Date	20160509
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	relm-20160331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 52 Cash Flow Statement 57

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.35M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$26.96M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$426.65K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.50M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.78M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$23.97M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$529.65K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$23.91K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$412.79K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$400.82K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.02M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.78M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.78M	shares	Point-in-time
Total assets	`Assets`	$24.39M	USD	Point-in-time
Total assets	`Assets`	$12.72M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.02M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$835.28K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$744.16K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.05M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$482.27K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	-	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$263.75K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$614.08K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$14.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.40M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$108.98K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$2.51M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.58M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 12,019,162 and 10,778,474 shares issued and outstanding, respectively	`CommonStockValue`	$12.02K	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 12,019,162 and 10,778,474 shares issued and outstanding, respectively	`CommonStockValue`	$10.78K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$84.92M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$85.97M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-76.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-75.78M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.81M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$12.72M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$24.39M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$5.59M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.01M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$609.12K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.27M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.14M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.30M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.52M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.69M	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$2.75M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$12.70M	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$13.11M	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$4.58M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-13.11M	USD	3 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-2.75M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-12.70M	USD	3 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-4.58M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$831.97K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$2.10M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$13.39M	USD	3 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-14.18M	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-149.00	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$778.00	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$5.16K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$2.30K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$54.56K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$10.48K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$20.96K	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$68.66K	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-14.15M	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$13.46M	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$887.31K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$2.12M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$342.70K	USD	3 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-26.85M	USD	3 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-1.86M	USD	1 Quarter
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-0.23	USD	1 Quarter
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-2.78	USD	3 Qtrs
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-0.15	USD	1 Quarter
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$0.03	USD	3 Qtrs
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-0.15	USD	1 Quarter
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$0.03	USD	3 Qtrs
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-2.78	USD	3 Qtrs
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-0.23	USD	1 Quarter
Weighted average number of common stock outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	11.46M	shares	3 Qtrs
Weighted average number of common stock outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.00M	shares	1 Quarter
Weighted average number of common stock outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	10.74M	shares	1 Quarter
Weighted average number of common stock outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	9.67M	shares	3 Qtrs
Weighted average number of common stock outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.74M	shares	1 Quarter
Weighted average number of common stock outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.00M	shares	1 Quarter
Weighted average number of common stock outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	9.67M	shares	3 Qtrs
Weighted average number of common stock outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.14M	shares	3 Qtrs

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$342.70K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-26.85M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-1.86M	USD	1 Quarter
Depreciation expense	`Depreciation`	$33.48K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$5.95K	USD	3 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$1.11M	USD	3 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$204.53K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$600.08K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$847.76K	USD	3 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$14.18M	USD	3 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-13.39M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$444.53K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-1.06M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-355.73K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-91.12K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$16.47K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$563.43K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$108.98K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.74M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.32M	USD	3 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$19.46K	USD	3 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$539.21K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-19.46K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-539.21K	USD	3 Qtrs
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	$13.44M	USD	3 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$263.75K	USD	3 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$293.63K	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.15M	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-263.75K	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$-11.12M	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$1.39M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$11.35M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$26.96M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$11.35M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$26.96M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Interest	`InterestPaid`	$2.66K	USD	3 Qtrs
Interest	`InterestPaid`	$4.49K	USD	3 Qtrs
Conversion of Class A convertible preferred stock to common stock	`ConvertiblePreferredStockToCommonStock`	$2.87K	USD	3 Qtrs
Conversion of Class A convertible preferred stock to common stock	`ConvertiblePreferredStockToCommonStock`	$72.00	USD	3 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`IssuancesOfCommonStockResultingFromCashlessExerciseOfWarrants`	-	USD	3 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`IssuancesOfCommonStockResultingFromCashlessExerciseOfWarrants`	$1.09K	USD	3 Qtrs
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	$263.80K	USD	Point-in-time
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	$263.75K	USD	3 Qtrs
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	$293.63K	USD	3 Qtrs
Cancellation of note payable for insurance premiums	`CancellationOfNotePayableInConnectionWithDirectorAndOfficerPolicy`	$55.22K	USD	3 Qtrs
Cancellation of note payable for insurance premiums	`CancellationOfNotePayableInConnectionWithDirectorAndOfficerPolicy`	-	USD	3 Qtrs
Reclassification of warrant liabilities to additional paid-in capital for warrant exercises	`ReclassificationOfWarrantLiabilitiesToAdditionalPaidInCapitalForWarrantExercises`	$15.30M	USD	3 Qtrs
Reclassification of warrant liabilities to additional paid-in capital for warrant exercises	`ReclassificationOfWarrantLiabilitiesToAdditionalPaidInCapitalForWarrantExercises`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.